Dr. Moroney is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5841 S Maryland Ave
Chicago, IL 60637Phone+1 888-824-0200Fax+1 772-702-5411
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Gynecologic Oncology, 2006 - 2009
National Capital ConsortiumResidency, Obstetrics and Gynecology, 2002 - 2006
Loyola University Chicago Stritch School of MedicineClass of 2002, M.D.
Certifications & Licensure
IL State Medical License 2015 - 2026
IN State Medical License 2016 - 2025
MT State Medical License 2023 - 2025
OH State Medical License 2009 - 2016
VA State Medical License 2004 - 2010
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Clinical Trials
- Pelvic Radiation Therapy or Vaginal Implant Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Stage I or Stage II Endometrial Cancer Start of enrollment: 2009 Mar 23
- Lymphedema After Surgery in Patients With Endometrial Cancer, Cervical Cancer, or Vulvar Cancer Start of enrollment: 2012 Jun 01
Publications & Presentations
PubMed
- 5 citationsNCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.Joyce Liu, Andrew Berchuck, Floor J Backes, Joshua Cohen, Rachel Grisham
Journal of the National Comprehensive Cancer Network. 2024-10-01 - 5 citationsNRG-GY012: Randomized phase 2 study comparing olaparib, cediranib, and the combination of cediranib/olaparib in women with recurrent, persistent, or metastatic endomet...Bobbie J Rimel, Danielle Enserro, David P Bender, Camille Gunderson Jackson, Annie Tan
Cancer. 2024-04-15 - 60 citationsMirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.Kathleen N Moore, Antoine Angelergues, Gottfried E Konecny, Yolanda García, Susana Banerjee
The New England Journal of Medicine. 2023-12-07
Press Mentions
ASCO Annual Meeting Returns to Chicago, Celebrates New Progress in CancerJune 15th, 2022
30 Cancer Symptoms You Should Never IgnoreOctober 31st, 2019
Accelerating Progress in Ovarian CancerAugust 16th, 2019- Join now to see all
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
